Qube Research & Technologies (QRT)
TEVA icon

Qube Research & Technologies (QRT)’s Teva Pharmaceuticals TEVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Buy
+59,306
New +$1.91M ﹤0.01% 2239
2025
Q2 		– Sell
-2,933,131
Closed -$47.3M – 3968
2025
Q1 		$45.1M Buy
2,933,131
+1,580,349
+117% +$28.2M 0.05% 440
2024
Q4 		$29.8M Buy
1,352,782
+126,145
+10% +$2.29M 0.04% 552
2024
Q3 		$22.1M Sell
1,226,637
-857,362
-41% -$15M 0.03% 629
2024
Q2 		$33.9M Buy
2,083,999
+2,022,219
+3,273% +$31.1M 0.05% 418
2024
Q1 		$872K Buy
+61,780
New +$779K ﹤0.01% 2229
2023
Q3 		– Sell
-1,618,232
Closed -$12.2M – 4332
2023
Q2 		$12.2M Buy
1,618,232
+226,841
+16% +$1.84M 0.04% 483
2023
Q1 		$12.3M Buy
+1,391,391
New +$13.8M 0.05% 406
2022
Q4 		– Sell
-2,216,584
Closed -$17.9M – 2991
2022
Q3 		$17.9M Buy
2,216,584
+1,933,334
+683% +$17.1M 0.11% 260
2022
Q2 		$2.13M Buy
+283,250
New +$2.47M 0.02% 781
2021
Q3 		– Sell
-348,175
Closed -$3.45M – 2763
2021
Q2 		$3.45M Buy
+348,175
New +$3.69M 0.04% 525
2020
Q4 		– Sell
-60,196
Closed -$542K – 2193
2020
Q3 		$542K Sell
60,196
-116,487
-66% -$1.23M 0.01% 1001
2020
Q2 		$2.18M Buy
+176,683
New +$2M 0.03% 633

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TEVA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 59,306 shares worth $1.79M. The stake represents ﹤0.01% of the portfolio and ranks #2239 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TEVA as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in TEVA in Q2 2020 and has held it in 13 quarters since. The position peaked at $45.1M in Q1 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 59,306 shares of Teva Pharmaceuticals worth $1.79M as of Q1 2026.
  • Teva Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2239 holding.
  • Qube Research & Technologies (QRT) first reported a position in Teva Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Teva Pharmaceuticals position peaked at $45.1M in Q1 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.